Skip to main content

Nautilus Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2083253 La Jolla, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$887,033
-$86,327 QoQ
Shares Held
7,021
+0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,131
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Nautilus Advisors LLC holds $5,916,229 across 6 Drug Manufacturers - General names. GILD ranks #3 (15.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 GILD
Gilead Sciences, Inc.
This page
7,021 $887,033

All Filings in GILD

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $887,033 7,021
2026-03-31 $973,360 6,984
2025-12-31 $858,443 6,994
2025-09-30 $794,538 7,158
2025-06-30 $793,496 7,157
2025-03-31 $801,941 7,157
2024-12-31 $668,019 7,232